Study principal investigator, Wayne Feng, M.D., M.S., professor of neurology and biomedical engineering at Duke University School of Medicine in Durham, North Carolina discusses the TRANSPORT 2 Trial (LB16) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles. Transcript (txt) TBA News release copyright American Heart Association 2025
The difference in atrial fibrillation risk was unexpected, surprising researchers.
Go Red for Women is the American Heart Association’s national movement to end heart disease and stroke in women. Learn more, get involved, and take…
AbstractBackground and Aims. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) impact iron metabolism in patients with heart failure but mechanisms are in
A Professor in the Division of Endocrinology, Dr. Grundy served as the founding director of the Center for Human Nutrition.
Ella Hayek, 11, and a partner won the third episode’s challenge on “Kids Baking Championship.” Two episodes later, she was sent home from the Food…
This editorial refers to ‘Sodium–glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease’, by J.W. Ostrominski et al
Surviving to thriving: Improving care for people living with a lifelong heart condition
Part of the benefit may be due to BP-lowering effects of the drug and/or fewer abnormal heart rhythms, says Seemant Chaturvedi.
The American Stroke Association is a relentless force for a healthier world with fewer strokes.
Vaccines are on the cutting edge of cancer therapy research as a possible treatment option for the future. The trial led by Yale Cancer Center…
